Literature DB >> 16880764

Systemically administered trefoil factors are secreted into the gastric lumen and increase the viscosity of gastric contents.

S Kjellev1, E Nexø, L Thim, S S Poulsen.   

Abstract

BACKGROUND AND
PURPOSE: Trefoil factors (TFFs) secreted by mucus-producing cells are essential for the defence of the gastrointestinal mucosa. TFFs probably influence the viscoelastic properties of mucus, but this has not been demonstrated in vivo. We therefore studied the gastric secretion of systemically administered TFF2 and TFF3, and their influence on the viscosity of the secretions. EXPERIMENTAL APPROACH: Mice and rats under general anaesthesia were injected intravenously with human (h) TFF2, hTFF3 (5 mg kg(-1) to mice and 25 mg kg(-1) to rats), murine (m) (125)I-TFF3, or (125)I-hTFF3 (300,000 cpm, mice only). The appearance of TFFs in the gastric mucosa and luminal secretions was analysed by autoradiography, gamma-counting, and ELISA, and the viscosity by rheometry. KEY
RESULTS: (125)I-mTFF3 and (125)I-hTFF3 were taken up by secretory cells of the gastrointestinal tract and detected at the gastric mucosal surface 15 min after injection. Stressing the stomach by carbachol (3.5 microg kg(-1)) and pyloric ligation significantly increased the uptake. Injected hTFF2, hTFF3, and mTFF3 were retrieved from the gastric contents after 4 h. In rats, an approximately seven-fold increase in the viscosity was detected after injection of TFF2 compared to the controls, whereas TFF3 did not increase the viscosity. In mice, TFF2 increased the viscosity approximately 4-fold.
CONCLUSIONS: These data indicate that systemically administered TFFs are transferred to the gastric lumen in a biologically active form.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16880764      PMCID: PMC1629411          DOI: 10.1038/sj.bjp.0706840

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  28 in total

1.  The human trefoil peptide, TFF1, is present in different molecular forms that are intimately associated with mucus in normal stomach.

Authors:  J L Newton; A Allen; B R Westley; F E May
Journal:  Gut       Date:  2000-03       Impact factor: 23.059

Review 2.  Molecular medicine of TFF-peptides: from gut to brain.

Authors:  W Hoffmann; W Jagla; A Wiede
Journal:  Histol Histopathol       Date:  2001-01       Impact factor: 2.303

3.  Effect of trefoil factors on the viscoelastic properties of mucus gels.

Authors:  L Thim; F Madsen; S S Poulsen
Journal:  Eur J Clin Invest       Date:  2002-07       Impact factor: 4.686

Review 4.  Trefoil factors: initiators of mucosal healing.

Authors:  Douglas Taupin; Daniel K Podolsky
Journal:  Nat Rev Mol Cell Biol       Date:  2003-09       Impact factor: 94.444

5.  Secretion of TFF-peptides by human salivary glands.

Authors:  W Jagla; A Wiede; M Hinz; K Dietzmann; D Gülicher; K L Gerlach; W Hoffmann
Journal:  Cell Tissue Res       Date:  1999-10       Impact factor: 5.249

6.  TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury.

Authors:  James J Farrell; Douglas Taupin; Theodore J Koh; Duan Chen; Chun-Mei Zhao; Daniel K Podolsky; Timothy C Wang
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

7.  Luminal and parenteral TFF2 and TFF3 dimer and monomer in two models of experimental colitis in the rat.

Authors:  Steen Seier Poulsen; Hannelouise Kissow; Kristine Hare; Bolette Hartmann; Lars Thim
Journal:  Regul Pept       Date:  2005-03-30

8.  Injected TFF1 and TFF3 bind to TFF2-immunoreactive cells in the gastrointestinal tract in rats.

Authors:  S S Poulsen; J Thulesen; B Hartmann; H L Kissow; E Nexø; L Thim
Journal:  Regul Pept       Date:  2003-09-15

9.  Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease.

Authors:  E M Vestergaard; J Brynskov; K Ejskjaer; J T Clausen; L Thim; E Nexø; S S Poulsen
Journal:  Scand J Clin Lab Invest       Date:  2004-04       Impact factor: 1.713

10.  Development and evaluation of an ELISA for human trefoil factor 3.

Authors:  Else Marie Vestergaard; Steen Seier Poulsen; Henning Grønbaek; Rune Larsen; Anette Mertz Nielsen; Kirsten Ejskjaer; Jes Thorn Clausen; Lars Thim; Ebba Nexø
Journal:  Clin Chem       Date:  2002-10       Impact factor: 8.327

View more
  12 in total

Review 1.  Structure, Function, and Therapeutic Potential of the Trefoil Factor Family in the Gastrointestinal Tract.

Authors:  Nayara Braga Emidio; Stuart M Brierley; Christina I Schroeder; Markus Muttenthaler
Journal:  ACS Pharmacol Transl Sci       Date:  2020-06-09

Review 2.  Trefoil Factor Peptides and Gastrointestinal Function.

Authors:  Eitaro Aihara; Kristen A Engevik; Marshall H Montrose
Journal:  Annu Rev Physiol       Date:  2016-12-15       Impact factor: 19.318

3.  MUC5B is the major mucin in the gel phase of sputum in chronic obstructive pulmonary disease.

Authors:  Sara Kirkham; Umme Kolsum; Karine Rousseau; Dave Singh; Jørgen Vestbo; David J Thornton
Journal:  Am J Respir Crit Care Med       Date:  2008-09-05       Impact factor: 21.405

Review 4.  Trefoil factors in inflammatory bowel disease.

Authors:  Luise Aamann; Else Marie Vestergaard; Henning Grønbæk
Journal:  World J Gastroenterol       Date:  2014-03-28       Impact factor: 5.742

5.  Different Forms of TFF2, A Lectin of the Human Gastric Mucus Barrier: In Vitro Binding Studies.

Authors:  Franziska Heuer; René Stürmer; Jörn Heuer; Thomas Kalinski; Antje Lemke; Frank Meyer; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2019-11-22       Impact factor: 5.923

6.  The TFF Peptides xP1 and xP4 Appear in Distinctive Forms in the Xenopus laevis Gastric Mucosa: Indications for Different Protective Functions.

Authors:  René Stürmer; Jana Reising; Werner Hoffmann
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

Review 7.  Pathological and therapeutic roles of bioactive peptide trefoil factor 3 in diverse diseases: recent progress and perspective.

Authors:  Yiqi Yang; Ziyang Lin; Quanyou Lin; Weijian Bei; Jiao Guo
Journal:  Cell Death Dis       Date:  2022-01-17       Impact factor: 8.469

8.  Excess Secretion of Gel-Forming Mucins and Associated Innate Defense Proteins with Defective Mucin Un-Packaging Underpin Gallbladder Mucocele Formation in Dogs.

Authors:  Mehmet Kesimer; John Cullen; Rui Cao; Giorgia Radicioni; Kyle G Mathews; Gabriela Seiler; Jody L Gookin
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

9.  Neural innervation stimulates splenic TFF2 to arrest myeloid cell expansion and cancer.

Authors:  Zina Dubeykovskaya; Yiling Si; Xiaowei Chen; Daniel L Worthley; Bernhard W Renz; Aleksandra M Urbanska; Yoku Hayakawa; Ting Xu; C Benedikt Westphalen; Alexander Dubeykovskiy; Duan Chen; Richard A Friedman; Samuel Asfaha; Karan Nagar; Yagnesh Tailor; Sureshkumar Muthupalani; James G Fox; Jan Kitajewski; Timothy C Wang
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 14.919

10.  Modulating bacterial and gut mucosal interactions with engineered biofilm matrix proteins.

Authors:  Anna M Duraj-Thatte; Pichet Praveschotinunt; Trevor R Nash; Frederick R Ward; Neel S Joshi
Journal:  Sci Rep       Date:  2018-02-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.